SUZANNE FREESEMANN: Open Payments
NPI 1285750430 · FULLERTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 17 payments from 7 companies in 2025. Trend: 2023 $609 · 2024 $781 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $186 |
| REVANCE THERAPEUTICS, INC. | 3 | $179 |
| Galderma Laboratories, L.P. | 1 | $155 |
| ABBVIE INC. | 3 | $137 |
| PFIZER INC. | 3 | $81 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $50 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
Products named: DUPIXENT, DAXXIFY, NEMLUVIO, SKYRIZI, CIBINQO, ILUMYA, YCANTH.
Industry payments across CA — which companies pay providers there.
